| P50 | author | Ruben Nogueiras | Q37831042 |
| P2093 | author name string | A Serrano | |
| | J Suárez | |
| | C Dieguez | |
| | A Vargas | |
| | F J Pavón | |
| | P Rivera | |
| | F Rodríguez de Fonseca | |
| | J Decara | |
| | S Arrabal | |
| P2860 | cites work | Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase | Q24309462 |
| | A role for glucagon-like peptide-1 in the central regulation of feeding | Q24314317 |
| | Long-acting glucagon-like peptide-1 receptor agonists have direct access to and effects on pro-opiomelanocortin/cocaine- and amphetamine-stimulated transcript neurons in the mouse hypothalamus | Q26749191 |
| | Neural control of white, beige and brown adipocytes | Q26751853 |
| | Pharmacology, physiology, and mechanisms of incretin hormone action | Q27021545 |
| | Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase | Q28215845 |
| | AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus | Q28254114 |
| | Use and abuse of HOMA modeling | Q28263292 |
| | betaAR signaling required for diet-induced thermogenesis and obesity resistance | Q28508047 |
| | Pharmacological Blockade of Cannabinoid CB1 Receptors in Diet-Induced Obesity Regulates Mitochondrial Dihydrolipoamide Dehydrogenase in Muscle | Q28551556 |
| | Neuronal GLP1R mediates liraglutide's anorectic but not glucose-lowering effect | Q30412673 |
| | The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss | Q30596646 |
| | Effects of the once-daily GLP-1 analog liraglutide on gastric emptying, glycemic parameters, appetite and energy metabolism in obese, non-diabetic adults | Q33737073 |
| | Calorie restriction increases fatty acid synthesis and whole body fat oxidation rates | Q33752629 |
| | 5' AMP-activated protein kinase activation causes GLUT4 translocation in skeletal muscle | Q33869428 |
| | Towards a molecular understanding of adaptive thermogenesis | Q33892351 |
| | GLP-1 analogs reduce hepatocyte steatosis and improve survival by enhancing the unfolded protein response and promoting macroautophagy | Q34034795 |
| | Prdm16 determines the thermogenic program of subcutaneous white adipose tissue in mice | Q34428994 |
| | Activation of human brown adipose tissue by a β3-adrenergic receptor agonist. | Q34456901 |
| | GLP-1 receptor activation inhibits VLDL production and reverses hepatic steatosis by decreasing hepatic lipogenesis in high-fat-fed APOE*3-Leiden mice | Q34469947 |
| | A randomized, phase 3 trial of naltrexone SR/bupropion SR on weight and obesity-related risk factors (COR-II) | Q34585609 |
| | Glp-1 analog, liraglutide, ameliorates hepatic steatosis and cardiac hypertrophy in C57BL/6J mice fed a Western diet | Q35925169 |
| | Anti-obesity efficacy of LH-21, a cannabinoid CB(1) receptor antagonist with poor brain penetration, in diet-induced obese rats | Q36147328 |
| | Elaidyl-sulfamide, an oleoylethanolamide-modelled PPARα agonist, reduces body weight gain and plasma cholesterol in rats. | Q36179973 |
| | Direct control of brown adipose tissue thermogenesis by central nervous system glucagon-like peptide-1 receptor signaling | Q36339639 |
| | Leptin-sensitive sensory nerves innervate white fat. | Q36923681 |
| | Adrenergic regulation of cellular plasticity in brown, beige/brite and white adipose tissues | Q37028404 |
| | Phentermine and topiramate extended-release: a new treatment for obesity and its role in a complications-centric approach to obesity medical management | Q37206308 |
| | Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans | Q37377728 |
| | Oleoylethanolamide enhances β-adrenergic-mediated thermogenesis and white-to-brown adipocyte phenotype in epididymal white adipose tissue in rat. | Q37438534 |
| | Sympathetic nervous system control of triglyceride metabolism: novel concepts derived from recent studies | Q37457206 |
| | Exenatide improves hepatic steatosis by enhancing lipid use in adipose tissue in nondiabetic rats | Q37629687 |
| | AMPK regulates lipid accumulation in skeletal muscle cells through FTO-dependent demethylation of N6-methyladenosine | Q37630806 |
| | The role of gastrointestinal hormones in hepatic lipid metabolism | Q37640700 |
| | Role of the glucagon-like-peptide-1 receptor in the control of energy balance | Q37708356 |
| | Incretin-based therapy and type 2 diabetes | Q37811422 |
| | Role of AMP-activated protein kinase in adipose tissue metabolism and inflammation. | Q38072478 |
| | Secretion of glucagon-like peptide-1 in patients with type 2 diabetes mellitus: systematic review and meta-analyses of clinical studies. | Q38078816 |
| | Age-related changes in AMPK activation: Role for AMPK phosphatases and inhibitory phosphorylation by upstream signaling pathways | Q38802628 |
| | GLP-1 receptor localization in monkey and human tissue: novel distribution revealed with extensively validated monoclonal antibody. | Q39030156 |
| | CL316,243, a β3-adrenergic receptor agonist, induces muscle hypertrophy and increased strength. | Q39164458 |
| | Study of the potential association of adipose tissue GLP-1 receptor with obesity and insulin resistance | Q39485654 |
| | Beta 3-adrenergic agonist up-regulates uncoupling proteins 2 and 3 in skeletal muscle of the mouse | Q40812155 |
| | Hypothalamic GLP-1: the control of BAT thermogenesis and browning of white fat. | Q41179606 |
| | Central GLP-1 receptor signalling accelerates plasma clearance of triacylglycerol and glucose by activating brown adipose tissue in mice | Q41553213 |
| | Hypothalamic neuropeptide Y (NPY) controls hepatic VLDL-triglyceride secretion in rats via the sympathetic nervous system | Q41941977 |
| | Exendin-4 increases oxygen consumption and thermogenic gene expression in muscle cells. | Q42502081 |
| | GLP-1 receptor agonism ameliorates hepatic VLDL overproduction and de novo lipogenesis in insulin resistance | Q42582553 |
| | Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study | Q43255700 |
| | Role of beta3-adrenoceptors for intrahepatic resistance and portal hypertension in liver cirrhosis | Q43258430 |
| | Insulin and contraction directly stimulate UCP2 and UCP3 mRNA expression in rat skeletal muscle in vitro | Q43588489 |
| | Acute effect of L-796568, a novel beta 3-adrenergic receptor agonist, on energy expenditure in obese men. | Q43961551 |
| | Food intake of lean and obese Zucker rats following ventricular infusions of adrenergic agonists | Q44349473 |
| | Effect of a beta-3 agonist on food intake in two strains of rats that differ in susceptibility to obesity | Q44995051 |
| | GLP-1 agonism stimulates brown adipose tissue thermogenesis and browning through hypothalamic AMPK. | Q46088562 |
| | Food restriction attenuates oxidative stress in brown adipose tissue of striped hamsters acclimated to a warm temperature | Q46551641 |
| | Expression of UCP2 in Wistar rats varies according to age and the severity of obesity | Q46631612 |
| | Comparative effects of the long-acting GLP-1 receptor ligands, liraglutide and exendin-4, on food intake and body weight suppression in rats | Q47385994 |
| | Direct control of peripheral lipid deposition by CNS GLP-1 receptor signaling is mediated by the sympathetic nervous system and blunted in diet-induced obesity | Q47868205 |
| | Skeletal muscle-specific HMG-CoA reductase knockout mice exhibit rhabdomyolysis: A model for statin-induced myopathy | Q47936139 |
| | Distribution and quantification of beta1-, beta2-, and beta3-adrenergic receptor subtype transcripts in porcine tissues | Q47967531 |
| | Antiobesity efficacy of GLP-1 receptor agonist liraglutide is associated with peripheral tissue-specific modulation of lipid metabolic regulators | Q48018517 |
| | GLP-1 receptor activation modulates appetite- and reward-related brain areas in humans | Q48632540 |
| | UCP2, UCP3 and leptin gene expression: modulation by food restriction and leptin | Q48711457 |
| | Dose response of subcutaneous GLP-1 infusion in patients with type 2 diabetes. | Q51378108 |
| | Lack of an effect of a novel beta3-adrenoceptor agonist, TAK-677, on energy metabolism in obese individuals: a double-blind, placebo-controlled randomized study. | Q51485054 |
| | AMPK phosphorylation of ACC2 is required for skeletal muscle fatty acid oxidation and insulin sensitivity in mice. | Q54345958 |
| | Glucagon-like peptide-1 reduces hepatic lipogenesis via activation of AMP-activated protein kinase. | Q54627651 |
| P433 | issue | 4 | |
| P304 | page(s) | e13008 | |
| P577 | publication date | 2017-11-28 | |
| P1433 | published in | Acta Physiologica | Q2662816 |
| P1476 | title | Cooperative role of the glucagon-like peptide-1 receptor and β3-adrenergic-mediated signalling on fat mass reduction through the downregulation of PKA/AKT/AMPK signalling in the adipose tissue and muscle of rats | |
| P478 | volume | 222 | |